InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: RRdog post# 127228

Tuesday, 06/11/2013 9:04:04 PM

Tuesday, June 11, 2013 9:04:04 PM

Post# of 346001
I found that post on Biotech Value Board... "Vinmantoo" replied that NSCLC was worth at least $4 Billion. (not saying he is right... nor I am right... but I believe I'm right ) My final calculation used for costs was $80,000 for the treatment and used 125,000 as number of patients.

This is the post from Biotech Value Board

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87494569

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News